Skip to content

Transcranial temporal interference stimulation for anhedonia in depression: A clinical randomized controlled trial

Transcranial temporal interference stimulation for anhedonia in depression: A clinical randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119459
Enrollment
Unknown
Registered
2026-02-27
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

Sponsors

Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age 18–60 years, right-handed, no gender restrictions; 2. Current episode or recurrent episode of DSM-5 Major Depressive Disorder (confirmed via MINI, supplemented with SCID-5 if necessary), no psychotic symptoms, current episode duration =4 weeks; 3. Stable psychiatric medication regimen: Current medication regimen maintained for at least 4 weeks prior to enrollment, or no initiation of new psychiatric medications within 4 weeks before enrollment; 4. Able to understand the study objectives and procedures, with capacity to sign informed consent; 5. Willing to actively cooperate with treatment after fully understanding the safety profile of tTIS, with informed consent signed by both the participant and family members.

Exclusion criteria

Exclusion criteria: 1. Other major mental disorders; or current presence of obsessive-compulsive disorder, PTSD, eating disorders, or anxiety disorders with significant functional impairment; 2. History of alcohol or substance abuse; 3. History of epilepsy, head surgery, or intracranial metal implants; 4. Presence of a pacemaker or other implanted electronic devices; 5. Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
SHAPS;

Secondary

MeasureTime frame
TEPS,HAMD-17, SDS,GAD-7;

Countries

China

Contacts

Public ContactTang Zhouping, Zhu Zhou

Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology

zhouzhu@hust.edu.cn+86 27 8366 3372

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026